These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 477026

  • 41. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs.
    Gardulf A, Andersen V, Björkander J, Ericson D, Frøland SS, Gustafson R, Hammarström L, Jacobsen MB, Jonsson E, Möller G.
    Lancet; 1995 Feb 11; 345(8946):365-9. PubMed ID: 7845120
    [Abstract] [Full Text] [Related]

  • 42. Individual patient variations in the kinetics of intravenous immune globulin administration.
    Pirofsky B, Campbell SM, Montanaro A.
    J Clin Immunol; 1982 Apr 11; 2(2 Suppl):7S-14S. PubMed ID: 7045157
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease.
    Cunningham-Rundles C, Siegal FP, Smithwick EM, Lion-Boulé A, Cunningham-Rundles S, O'Malley J, Barandun S, Good RA.
    Ann Intern Med; 1984 Oct 11; 101(4):435-9. PubMed ID: 6206756
    [Abstract] [Full Text] [Related]

  • 45. Use of a new chemically modified intravenous IgG preparation in severe primary humoral immunodeficiency: clinical efficacy and attempts to individualize dosage.
    Schiff RI, Rudd C, Johnson R, Buckley RH.
    Clin Immunol Immunopathol; 1984 Apr 11; 31(1):13-23. PubMed ID: 6421523
    [Abstract] [Full Text] [Related]

  • 46. Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency.
    Berger M.
    Immunol Allergy Clin North Am; 2008 May 11; 28(2):413-37, x. PubMed ID: 18424340
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Prophylaxis and treatment of diseases by means of immunoglobulins.
    Barandun S, Skvaril F, Morell A.
    Monogr Allergy; 1975 May 11; 9():39-60. PubMed ID: 123313
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Clinical efficacy of immunostimulating drugs in treatment of purulent infections].
    Zemskov AM, Zemskov VM, Tokmakov AI.
    Khirurgiia (Mosk); 2011 May 11; (2):4-10. PubMed ID: 21378699
    [Abstract] [Full Text] [Related]

  • 56. [Humoral immunodeficiencies and their substitution treatment].
    Hitzig WH.
    Presse Med; 1983 Nov 17; 12(41):2563-6. PubMed ID: 6228791
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Treatment of AB deficiencies.
    Cunningham-Rundles C.
    Vox Sang; 1986 Nov 17; 51 Suppl 2():63-8. PubMed ID: 3490056
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.